Citadel Advisors - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2015$71,000
+10.9%
4,200
-27.6%
0.00%
Q3 2015$64,000
-32.6%
5,800
-23.7%
0.00%
Q2 2015$95,000
-52.0%
7,600
-57.8%
0.00%
Q1 2015$198,000
+43.5%
18,000
+102.2%
0.00%
Q4 2014$138,000
-14.8%
8,900
-33.6%
0.00%
Q3 2014$162,000
-30.2%
13,400
-26.0%
0.00%
Q2 2014$232,000
+101.7%
18,100
+90.5%
0.00%
Q1 2014$115,000
+117.0%
9,500
+102.1%
0.00%
Q4 2013$53,000
-81.5%
4,700
-82.8%
0.00%
Q3 2013$286,000
+157.7%
27,400
+185.4%
0.00%
Q2 2013$111,0009,6000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,685$28,560,0003.66%
BOOTHBAY FUND MANAGEMENT, LLC 158$963,0000.10%
GROUP ONE TRADING, L.P. 140,900$8,589,0000.07%
SIMPLEX TRADING, LLC 667$4,066,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEKTAR THERAPEUTICS shareholders